Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMICUS THERAPEUTICS, INC. Director's Dealing 2010

Jun 16, 2010

31523_dirs_2010-06-16_60ed8588-e15a-45c0-b47e-f55e1c62e2c0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2010-06-15

Reporting Person: BARKAS ALEXANDER E (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-06-15 Stock Options (right to buy) $2.81 A 10000 Acquired 2020-06-15 Common Stock (10000) Direct

Footnotes

F1: One hundred percent of the shares subject to this option will vest and become exercisable on the date of the annual meeting of the stockholders of the issuer to be held in 2011, provided that if the reporting person ceases to be a director of the issuer, this option shall cease to be exercisable in any respect not later than ninety (90) days following that event.